Volume 72; Issue 2

Cancer Chemotherapy and Pharmacology

Volume 72; Issue 2

1

Synergistic interactions between camptothecin and EGFR or RAC1 inhibitors and between imatinib and Notch signaling or RAC1 inhibitors in glioblastoma cell lines

Sooman, Linda, Ekman, Simon, Andersson, Claes, Kultima, Hanna GÃ¶ransson, Isaksson, Anders, Johansson, Fredrik, Bergqvist, Michael, Blomquist, Erik, Lennartsson, Johan, Gullbo, Joachim

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2013

Language:

english

File:

PDF, 545 KB

english, 2013

2

The pharmacokinetics of letrozole in brain and brain tumor in rats with orthotopically implanted C6 glioma, assessed using intracerebral microdialysis

Dave, Nimita, Gudelsky, Gary A., Desai, Pankaj B.

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2013

Language:

english

File:

PDF, 279 KB

english, 2013

3

Phase II study of single agent oral vinorelbine as first-line treatment in patients with HER-2 negative metastatic breast cancer

Mansour, Maged, Mourad, Cynthia

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2013

Language:

english

File:

PDF, 244 KB

english, 2013

4

Long-term efficacy of imatinib for treatment of metastatic GIST

Shreyaskumar Patel

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2013

Language:

english

File:

PDF, 322 KB

english, 2013

5

CYP2D6 polymorphisms influence tamoxifen treatment outcomes in breast cancer patients: a meta-analysis

Zhiyu Zeng, Yanqiong Liu, Zhiming Liu, Jianpeng You…

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2013

Language:

english

File:

PDF, 540 KB

english, 2013

6

Association between GSTP1 Ile105Val polymorphism and oxaliplatin-induced neuropathy: a systematic review and meta-analysis

Zhi Peng, Qianqian Wang, Jing Gao, Zhaoning Ji…

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2013

Language:

english

File:

PDF, 448 KB

english, 2013

7

Polymorphisms in ERCC1 C8092A predict progression-free survival in metastatic/recurrent nasopharyngeal carcinoma treated with cisplatin-based chemotherapy

Cui Chen, Fenghua Wang, Zhiqiang Wang, Cong Li…

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2013

Language:

english

File:

PDF, 238 KB

english, 2013

8

Multicenter phase II study of capecitabine combined with nedaplatin for recurrent and metastatic nasopharyngeal carcinoma patients after failure of cisplatin-based chemotherapy

Pei-Jian Peng, Xue-Qing Ou, Zhi-Bin Chen, Hai Liao…

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2013

Language:

english

File:

PDF, 212 KB

english, 2013

9

Significant increase in hEGF uptake is correlated with formation of EGFR dimers induced by the EGFR tyrosine kinase inhibitor gefitinib

Peng He, Gang Li

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2013

Language:

english

File:

PDF, 630 KB

english, 2013

10

Hepatic activation of irinotecan predicts tumour response in patients with colorectal liver metastases treated with DEBIRI: exploratory findings from a phase II study

R. P. Jones, P. Sutton, R. M. D. Greensmith…

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2013

Language:

english

File:

PDF, 361 KB

english, 2013

11

Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments

Jennifer L. Pauley, John C. Panetta…

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2013

Language:

english

File:

PDF, 391 KB

english, 2013

12

A phase I, open-label, mass balance study of [14C] dacomitinib (PF-00299804) in healthy male volunteers

Carlo L. Bello, Evan Smith, Ana Ruiz-Garcia…

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2013

Language:

english

File:

PDF, 326 KB

english, 2013

13

Safety, tolerability, pharmacokinetics, and pharmacodynamics of a long-acting release (LAR) formulation of pasireotide (SOM230) in patients with gastroenteropancreatic neuroendocrine tumors: results from a randomized, multicenter, open-label, phase I study

Edward M. Wolin, Ke Hu, Gareth Hughes…

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2013

Language:

english

File:

PDF, 401 KB

english, 2013

14

Epidermal growth factor receptor (EGFR) andKRASmutations during chemotherapy plus anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer

David Tougeron, Ulrich Cortes, Aurélie Ferru…

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2013

Language:

english

File:

PDF, 274 KB

english, 2013

15

Death receptor 5 agonistic antibody PRO95780: preclinical pharmacokinetics and concentration–effect relationship support clinical dose and regimen selection

Hong Xiang, Arthur E. Reyes II, Steve Eppler…

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2013

Language:

english

File:

PDF, 553 KB

english, 2013

16

Validation of tumour models for use in anticancer nanomedicine evaluation: the EPR effect and cathepsin B-mediated drug release rate

Ruth Duncan, Yee-Nee Sat-Klopsch…

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2013

Language:

english

File:

PDF, 591 KB

english, 2013

17

A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer

Ibrahim Yildiz, Faruk Tas, Leyla Kilic, Fatma Sen…

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2013

Language:

english

File:

PDF, 210 KB

english, 2013

18

Maintenance therapy with pemetrexed versus docetaxel after induction therapy with carboplatin and pemetrexed in chemotherapy-naïve patients with advanced non-squamous non-small-cell lung cancer: a randomized, phase II study

Masato Karayama, Naoki Inui, Shigeki Kuroishi…

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2013

Language:

english

File:

PDF, 219 KB

english, 2013

19

Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab

Matthew D. Hellmann, Jamie E. Chaft, Valerie Rusch…

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2013

Language:

english

File:

PDF, 246 KB

english, 2013

20

A multi-institutional phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis

Masafumi Ikeda, Takuji Okusaka, Junji Furuse…

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2013

Language:

english

File:

PDF, 225 KB

english, 2013

21

A predictive pharmacokinetic–pharmacodynamic model of tumor growth kinetics in xenograft mice after administration of anticancer agents given in combination

Nadia Terranova, Massimiliano Germani…

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2013

Language:

english

File:

PDF, 532 KB

english, 2013

22

DMET™ (Drug-Metabolizing Enzymes and Transporters) microarray analysis of colorectal cancer patients with severe 5-fluorouracil-induced toxicity

Enrica Rumiato, Elisa Boldrin, Alberto Amadori…

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2013

Language:

english

File:

PDF, 184 KB

english, 2013

23

Ipilimumab-induced endocrinopathies: when to start corticosteroids (or not)

Salvatore Maria Corsello, Roberto Salvatori…

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2013

Language:

english

File:

PDF, 107 KB

english, 2013

24

Erratum to: Differential toxicity biomarkers for irinotecan- and oxaliplatin- containing chemotherapy in colorectal cancer

Lucía Cortejoso, María I. García…

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2013

Language:

english

File:

PDF, 124 KB

english, 2013